TNDM

Tandem Diabetes Care, Inc.

21.55

USD

TNDM Earnings Reports

Positive Surprise Ratio

TNDM beat 20 of 40 last estimates.

50%

Next Report

Date of Next Report

Feb 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

$282.30M

-$0.09

Implied change from Q3 25 (Revenue/ EPS)

+13.26%

-70.97%

Implied change from Q4 24 (Revenue/ EPS)

-0.12%

-1000.00%

Tandem Diabetes Care, Inc. earnings per share and revenue

On Nov 06, 2025, TNDM reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 3.19% surprise. Revenue reached 249.25 million, compared to an expected 241.70 million, with a 3.12% difference. The market reacted with a +21.98% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 25 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 282.30 million USD, implying an decrease of -70.97% EPS, and increase of 13.26% in Revenue from the last quarter.

FAQ

What were Tandem Diabetes Care, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Tandem Diabetes Care, Inc. reported EPS of -$0.31, beating estimates by 3.19%, and revenue of $249.25M, 3.12% above expectations.

How did the market react to Tandem Diabetes Care, Inc.'s Q3 2025 earnings?

The stock price moved up 21.98%, changed from $13.33 before the earnings release to $16.26 the day after.

When is Tandem Diabetes Care, Inc. expected to report next?

The next earning report is scheduled for Feb 24, 2026.

What are the forecasts for Tandem Diabetes Care, Inc.'s next earnings report?

Based on 25 analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.09 and revenue of $282.30M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.